Stock listing

OTC:GNMLF Genomma Lab Internacional SAB de CV Stock

US listing (OTC) of Genomma Lab Internacional SAB de CV · home listing BMV:LABB

Follow Genomma Lab Internacional SAB de CV into a list and get an email when it puts out news.

Share price · OTC:GNMLF

$0.722 USD

Close on Oct 16, 2026

Day range
$0.722 – $0.762 USDOct 16, 2026
Volume
10,000 sharesOct 16, 2026
Market cap
$706.1M USDAt the close on Oct 16, 2026 · price × 977.8M shares outstanding
Genomma Lab Internacional SAB de CV logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
OTC:GNMLF$0.722 USD—10,000$0.762$0.762$0.722—Close on Oct 16, 2026
Frankfurt:GEKA€0.66 EUR—1,500€0.66€0.66€0.66—Close on Oct 22, 2026
Ticker
OTC:GNMLF
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
OTC
Currency
USD

What changed lately

Calls

Replays

  • Genomma Lab Internacional Sab de CV (BMV:LAB/B) Q2 2026 Earnings Call

    Thu, Jul 23, 2026 · 1:00 PM ET

    Watch Transcript

  • Genomma Lab Internacional Sab de CV (BMV:LAB/B) Q1 2026 Earnings Call

    Thu, Apr 23, 2026 · 1:00 PM ET

    Watch Transcript

  • Genomma Lab Internacional Sab de CV (BMV:LAB/B) Q1 2025 Earnings Call

    Fri, May 02, 2025 · 1:00 PM ET

    Watch Transcript

Latest news

LAB/B: Net sales fell 4.9% as FX and weak demand weighed, but LATAM growth and margin gains offset declines

Apr 23, 2026

LAB/B: Margins held strong despite sales decline, with recovery and growth initiatives set for 2026

Feb 26, 2026

LAB/B: Sales declined due to hyperinflation and weak demand, but margins and cost controls remained strong

Oct 23, 2025

LAB/B: Solid EBITDA margin and free cash flow growth offset weak sales and currency headwinds

Jul 24, 2025

LAB/B: Q1 2025 saw robust EBITDA and EPS growth, with strong cash flow and margin gains

May 2, 2025

LAB/B: Exceptional 2024 results: strong sales, record profits, margin expansion, and robust cash flow

Feb 27, 2025

LAB/B: Q3 delivered robust sales, margin, and cash flow growth, with strong outlook and disciplined capital use

Oct 24, 2024

LAB/B: Q2 2024 delivered strong profit growth, margin expansion, and strategic M&A activity

Jul 25, 2024

All Genomma Lab Internacional SAB de CV news

Decks

Genomma Lab Internacional SAB de CV on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
2 in the last 12 months · 8 in all · newest Apr 23, 2026 · oldest 2024
Calls
19 calls with a replay · 19 with a transcript · latest Jul 23, 2026
Decks
15 decks · latest Apr 1, 2026

Where Genomma Lab Internacional SAB de CV is listed

ListingExchangeCountryCurrency
BMV:LABB · Home listingBMVMexicoMXN
BIVA:LABBBIVAMexicoMXN
LS Exchange:A0Q4TCLS ExchangeGermanyEUR
Lang & Schwarz:A0Q4TCLang & SchwarzGermanyEUR
OTC:GNMLF · This pageOTCUnited StatesUSD
Dusseldorf:GEKADusseldorfGermanyEUR
Frankfurt:GEKAFrankfurtGermanyEUR

Log in to ask 6ix AI your own questions about Genomma Lab Internacional SAB de CV.